Loading...
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Pancreatic ductal adenocarcinoma (PDAC) has one of the highest mortality rates among all cancer types. Its delayed diagnosis precludes curative resection, thus most of the current therapies against PDAC are based on chemo- and radiotherapy. Unfortunately, these strategies are insufficient to improve...
Na minha lista:
| Udgivet i: | Cancer Biol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Chinese Anti-Cancer Association
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6936232/ https://ncbi.nlm.nih.gov/pubmed/31908888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2019.0252 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|